Strides Pharma Science Limited
STAR.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$100.04B
Close$
Share Statistics
| Market cap | $100.04 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $5.00 (0.46%) |
| Earnings per Share | $60.34 |
| Beta | 0.39 |
| Outstanding Shares | 92,172,710 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 16.31 |
|---|---|
| PEG | 28.34 |
| Price to Sales | 1.99 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$13.32 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$14.15 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Strides Pharma Science Limited
3,535 employees
CEO: Badree Komandur Established in 1990 and based in Bengaluru, India, Strides Pharma Science Limited operates as an international pharmaceutical company, involved in the creation, production, and sale of a wide array of pharmaceutical products. Its operati...